DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ornipressin
Ornipressin
Pharmaceutical Appendix to the Tariff Schedule 2
The V2 Receptor Antagonists
Queensland Health List of Approved Medicines
INN Working Document 05.179 Update December 2010
Ep 2326341 B1
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Vasopressin: Its Current Role in Anesthetic Practice
Clinical Decisions in Pediatric Nephrology Farahnak Assadi, M.D
Who Expert Committee on Specifications for Pharmaceutical Preparations
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Poison Or Antibiotic? a Guide to "Class" Entries
Customs Tariff - Schedule
WO 2007/085087 Al
Auspar Attachment 2: Extract from the Clinical Evaluation Report For
The Role of V2 Receptor Antagonists in the Treatment of Hyponatremia
Issue #105-116, 1978
Top View
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Customs Tariff - Schedule Xxi - 1
EASL Clinical Practice Guidelines on the Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis
Mesh Terms for 2002
Prescribing Medicines in Pregnancy
(12) United States Patent (10) Patent No.: US 6,680,047 B2 Klaveness Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Review Article
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
10 Park Nephrology
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
For Pharmaceutical Substances 2002
Association of Vasopressin Plus Catecholamine
Association of Vasopressin Plus Catecholamine
Pharmaceutical Appendix to the Tariff Schedule 2
Nam Eml 2008.Pdf
Management of the Neurologically Deceased Organ Donor: a Canadian Clinical Practice Guideline
WO 2017/040864 Al 9 March 2017 (09.03.2017) P O P C T